~~<i id='93151ED529'><strike id='93151ED529'><tt id='93151ED529'><pre id='93151ED529'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

explore

author：focus 2025-08-06 05:20:37 - browse：78751

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

explore

knowledge

hotspot

Wikipedia

knowledge

Wikipedia

Illustrationofmitochondria,powerhouseofthecell.AdobeAselitehuntersoftheimmunesystem,Tcellsareconstan

WSS

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

The real point of Kenneth Smith’s execution by nitrogen gas

Female surgeons have lower rates of long

Vertex non

Female surgeons have lower rates of long

Cybersecurity threat forces Lurie Children's to take systems offline

entertainment

explore

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How clinical AI models' predictive power can degrade over time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Nick Jonas talks about managing diabetes along with his career

Heart attack and stroke risk calculators need revising

Medicare to cover more brain scans related to Alzheimer’s drugs

Heart attack and stroke risk calculators need revising

Peter Marks talks Operation Warp Speed for Rare Diseases

Dobbs anniversary: the lost opportunity of abortion as health care

Congressmen charge Covid hearing ‘could have been an email’

knowledge

Readout LOUD podcast: Merger Mondays, Ozempic panic

ARCH Venture Partners is raising $3 billion for a life sciences fund

Researchers CRISPR chickens in bid to protect them from bird flu

A revolution in caring for preterm infants

Do digital therapeutics have a future in medicine?

How clinical AI models' predictive power can degrade over time

hotspot

Wikipedia

knowledge

Wikipedia